Suntory Beverage & Food2587.T
The cheapness is the hook. SBF trades at its decade low on every multiple — 14.3x forward, 1.02x book, the worst ten-year total return in its bucket — and the inherited reading filed it as the cleanest quality unjustly confiscated by governance. Pull the consolidated 8.7% margin apart, take the yen out of it, and the discount thins to nothing : a quality grower fairly valued at its floor, not a deep-value franchise. What is left to decide is narrower. Whether a parental lock that ten years of market has refused to pay through can be broken by a single corporate act.
Europe, the highest-margin pole at 15.8%, normalises to roughly ¥57bn of operating profit. On the 11.0x multiple its return on capital earns — not the premium its margin alone would suggest — it is worth about ¥627bn.
Japan at 8.5x, Asia-Pacific at 10.0x and the Americas at 11.0x add about ¥1,020bn between them ; the unallocated head-office cost line removes ¥258bn. Gross enterprise value reconstructs to ¥1,389bn, a blended 10.1x.
Net cash of ¥69bn, less ¥16bn of pension obligation and ¥190bn of minority interest, brings equity to ¥1,252bn, or ¥4,052 per share.
The market capitalises SBF at ¥1,346.6bn. Once the yen is normalised and the minorities are deducted, the discount the inherited thesis was built on is not in the numbers.
The interesting thing about SBF is not that it is cheap, it is why it is cheap. Every multiple sits at its decade low — 14.3x forward earnings, 6.5x EV/EBITDA, 1.02x book — and the stock has the worst ten-year total return in its bucket, +0.6%. The inherited reading treats that as a single dislocation : the best franchise of the four, held under glass by a controlling parent, waiting for the lock to break. Pull the consolidated 8.7% margin apart and the cheapness has three quieter explanations rather than one mispricing.
The first is a base effect. The headline decade EPS CAGR of +7.6% rests entirely on the J-GAAP FY2015 trough of 137¥. Measured on the first full IFRS year — FY2016 231¥ to FY2025 287¥ — real per-share compounding is closer to +2%/yr. The asset has grown revenue +32% over the window without compounding its economics. It is a quality grower, not a compounder, and a compounder's multiple was never the right tool.
The second is geography. The margin is European, not Japanese : 23% of revenue earns 35% of segment profit at a 15.8% margin in Europe, against 6.4% in Japan on 43% of revenue. And a large part of the recent revenue line is yen, not pricing — Q1 FY2026 grew +11.2% reported but +6.1% currency-neutral, a ~5-point currency gap. The reported strength reads better than the structural earnings power underneath it.
The third closes the case. Normalise the yen out, deduct the minorities, and price Europe on its 9.0% return on capital rather than its 15.8% margin, and the cellular sum of the parts lands near ¥4,050 — just below the ¥4,358 spot. The decade-low multiple is a fair value, not a bargain. What looks like a confiscated quality discount is largely an FX illusion, a low-return European pole, and the leak of profit to minority joint-ventures.
That leaves an asset fairly valued at its floor, carrying one lever the price does not hold : a governance act. Ten years of market has declined to pay through Suntory Holdings' 59.48% control, and the sectoral law is unambiguous that performance alone will not re-rate the name. Only a corporate event does — a buyback at 1.0x book, a reduction in the parent stake, a royalty cap. The position framing is patient observation, not ownership : conditional long bias, 0% sizing, moderate conviction. The catalyst is real and undated, and it has already disappointed once.
The decade reads as three regimes. From the 2013 IPO to about 2018, the market paid for an internationalisation story — Lucozade and Ribena, Orangina and Schweppes, the Pepsi bottling joint-ventures — and an Abenomics re-flation, on multiples of 20–40x earnings and 2.2–2.8x book. From 2018 to 2022 those multiples compressed steadily while the company deleveraged in the background, taking net debt of ¥136bn down to a net cash position by FY2022 ; the pricing power of a brand owner was paid for exactly once, in the inflation of 2024. The current regime, from 2022, is input pressure, growth capex and a governance floor : revenue ran to ¥1.72tn on currency and emerging-market volume and price, but the margin contracted, free cash flow collapsed, and every multiple touched its decade low.
| Inflection | FY 2015J-GAAP trough | FY 2019IFRS base | FY 2022Net cash | FY 2024Peak EBIT | FY 2025Recovery floor |
|---|---|---|---|---|---|
| Revenue (¥bn) | 1,381.0 | 1,299.4 | 1,450.4 | 1,696.8 | 1,715.4 |
| EBIT (¥bn) | 92.0 | 113.9 | 139.3 | 160.1 | 148.8 |
| EBIT margin | 6.7% | 8.8% | 9.6% | 9.4% | 8.7% |
| Return on capital | 4.7% | 7.6% | 8.6% | 8.9% | 7.8% |
| FCF (¥bn) | 86.7 | 111.8 | 90.3 | 85.4 | 65.3 |
| FCF / EBIT | 94% | 98% | 65% | 53% | 44% |
| Net debt (¥bn) | +339.0 | +110.2 | −31.7 | −75.2 | −69.2 |
| Net income owners (¥bn) | 42.5 | 68.9 | 82.3 | 93.5 | 88.7 |
| Diluted EPS (¥) | 137.4 | 222.9 | 266.4 | 302.6 | 287.1 |
Source: Data pack 22 June 2026. EBIT = reported operating income. FY2015 is J-GAAP (IFRS adopted FY2017) ; the FY2015 net income and 54.5% gross margin are non-comparable artefacts that flatter any CAGR anchored on that base. Net cash was reached at FY2022. Net debt is positive (net debt) at FY2015–2019, negative (net cash) thereafter.
Three decisions explain the shape. The 2013 IPO at a minority float was the original governance sin : by keeping ~59.5% of the capital, the control, the brand and a royalty, the parent locked in a discount that neither performance nor deleveraging could resorb — a de-rating the sectoral work puts at ~7–9%/yr, enough to annihilate the per-share growth on the way to a +0.6% ten-year return. The growth capex was then allowed to run without discipline : it nearly doubled, from ~¥57bn to ¥94–108bn, while the cash conversion cycle stretched from 13 to 53 days and return on capital slipped from 8.9% to 7.8% — capital deployed faster than it returned. And no share was ever repurchased, at 1.0x book and a decade-low multiple, where a buyback would have been sharply accretive. The deleveraging from +¥339bn to net cash was the real per-share value creation of the decade, and it is now exhausted as a lever.
The engine only makes sense at the segment level, because the four geographic poles are economically different businesses pretending to be one. The certified FY2025 maille shows the spread plainly. Japan earns ¥46.9bn of operating profit at a 6.4% margin on 43% of revenue. Europe earns ¥61.6bn at 15.8% on 23%. Asia-Pacific earns ¥42.5bn at 10.8%, the Americas ¥23.5bn at 12.0%. A single 8.7% group number is the weighted average of a European margin franchise and a declining Japanese volume base — which is exactly why a single consolidated multiple is the wrong instrument, and why the ~900-basis-point dispersion forces a sum of the parts.
The most important thing the segment data reveals is that the margin ranking inverts in return on capital. Measured on segment return on non-current assets, the order is Americas 21.2%, Asia-Pacific 14.8%, Japan 12.9%, then Europe last at 9.0%. The highest-margin pole is the least capital-efficient, because the acquisition premium for Orangina and Lucozade — 47% of group non-current assets — is immobilised in its capital base. Europe is a margin engine, not a return engine, and the value created at the margin comes as much from the Americas and Asia as from Europe. The consolidated P&L erases this distinction entirely.
The cost that drives the margin is double, and both halves are structural. Inputs and logistics come first — PET, sugar, aluminium, coffee — passing through with a one-to-two-quarter lag, and in Japan at the cost of volume, which is why gross margin has eroded from ~41% to 37.4%. Marketing is the quiet second : cited at every pole as a drag, the defence of the brands demands a rising marketing intensity that caps margin expansion. The pricing power is real — Europe raises price as revenue rises, Japan raises price too — but it is partly masked and partly inflated by the yen, and the FY2026 guidance runs on USD/JPY 150 and EUR/JPY 180. Normalised to house ¥130/$ and ¥150/€, operating profit falls about 7% to ~¥138bn, an ~8.3% structural margin. Q1 FY2026 made the point cleanly : revenue +6.1% currency-neutral, operating profit −7.2% on the same basis.
What protects the downside is the balance sheet. Net cash of ¥69bn finances the investment cycle without leverage, the pension is 85% funded, interest cover runs near 38x. That dormant net cash is the real option in the name, and the price gives it almost no weight.
Governance is the cardinal pillar because it is the binding constraint and the only one whose change re-rates the name. Suntory Holdings controls 59.48%, unchanged since the 2013 IPO. The return is dividend-only — a stable payout of 42%, 120¥ a share, and no buyback in ten years, at 1.0x book and a decade-low multiple, where a repurchase would be sharply accretive. A brand royalty runs to the parent at ~1.4% of sales ; modest, plausibly arm's-length, and not the rapacious extraction the inherited thesis assumed. The discount is one of control, capital allocation and float illiquidity, not royalty. Ten years of market has refused to pay through the lock, and only a corporate act releases it.
The economic model is the second cardinal because it decides whether the quality is real or merely reported. Return on capital of 7.8% clears the house cost of capital at 6.0% but only matches the WACC near 7%, and it is falling — 8.9% to 7.8% across FY2024–25. Cash conversion has collapsed : FCF/EBIT 44%, free cash flow margin 3.8%, on growth capex that doubled without an incremental return. The net cash balance sheet keeps the model off the floor and the franchise off a value-trap reading. But at the flow level capital is being deployed faster than it returns, and the normalised free cash yield of ~5.7% barely covers the cost of equity.
A defensive staple with a real brand portfolio and an Oceania relay growing +66% in Q1. The Japanese volume base, 43% of revenue, is in structural decline held up by price ; the emerging relay is cyclical and FX-sensitive ; there is no contractual recurrence.
Heritage brands — Orangina, Lucozade, BOSS — with real regional pricing power, which the 15.8% European margin demonstrates. The limits are reach and durability : switching costs are nil in FMCG, gross margin is eroding from 41% to 37.4%, and the moat is regional rather than global.
Successful deleveraging and genuine FX transparency through currency-neutral reporting, set against a weak execution record : the mid-term plan's >10% margin target already missed at 8.5% guided, return on capital falling, capex undisciplined, and a CEO transition adding uncertainty.
A B+ quality contradicted by its cage. SBF has the only ex-cash return above cost of capital in its bucket, yet sits below a governance pillar that caps the whole valuation — the score measures the captivity, not the economic engine underneath. The grade is consistent with the valuation : fairly valued at the floor, no premium earned on the consolidated line and no discount left to claim once the parts are summed, with the re-rating gated on a single governance lever.
Is the governance discount a permanent floor, or resorbable on a catalyst ?
Is the margin structural, or yen-flattered and marketing-eroded ?
One camp reads the record revenue and the ~9% margin as a normalised earnings power ; the other sees a margin inflated by the yen and worn down by a rising marketing bill. The currency-neutral evidence favours the second. Q1 FY2026 operating profit fell −7.2% currency-neutral despite +6.1% revenue, the operating leverage turning negative once the yen is stripped out, and the >10% mid-term target is missed at 8.5% guided. At house FX the margin sits materially below the reported line.
Does the growth capex create value, or destroy it ?
One camp capitalises the ¥2.5tn-by-2030 ambition as future value creation ; the other sees capital deployed without return. The record so far favours the second : capex nearly doubled from ~¥57bn to ¥94–108bn while return on capital fell from 8.9% to 7.8% and FCF/EBIT dropped to 44%. The incremental return on the growth capex is, at this stage, below the cost of capital — the open question is whether the spending is transitory, ending with the 2030 cycle, or a structural draw on returns.
At ¥4,358, on 14.3x forward earnings, ~10x normalised EV/EBIT and 1.02x book, the market prices flat-to-mid-single-digit owner EPS in perpetuity — FY2026 guidance is +0.3% — a permanent governance haircut at zero franchise premium to book, and no buyback optionality, the February 2026 disappointment already in the price. The tell is the year to date : SBF is the worst performer in its bucket at −7.8% while CCBJI re-rated. The headline decade-low multiples read like a discount, but that reading is a denominator artefact and a refusal to penalise a low-return European pole. Normalise the yen out and sum the parts on return on capital, and the sum reconstructs onto the market cap. The floor of value is the book and the net cash at 1.0x, not the free cash yield, which at 5.7% normalised barely covers the cost of equity.
Currency-neutral operating profit stays negative under marketing and input pressure and the Japanese volume decline ; Vietnam and Thailand weakness persists ; growth capex keeps eroding return on capital ; no catalyst prolongs the de-rating. This is a timing disappointment, reversible. The defensible floor holds at ~¥3,800, 0.9x book, because the net cash of −¥69bn and the real European franchise underpin it ; the −25% modelled level is a sentiment overshoot, not a permanent impairment.
The plan executes without surprise — organic mid-single-digit growth, an ~8.3% normalised margin, growth capex maintained, dividend-only return, no governance act. The market keeps pricing the quality at the floor. The cellular sum of the parts on ~¥138bn of normalised operating profit lands at a centre of ~¥4,065, just below spot. A consolidated re-rating may or may not come ; the fair value does not need it. The point is that it lands on the spot.
The incoming CEO and new mid-term plan deliver a governance act — a material buyback at 1.0x book that is sharply accretive, plus a disciplined allocation framework — while growth capex normalises toward 55–60% conversion and the Oceania and Americas relays accelerate. The re-rating is book-driven, the only vector the sectoral law allows. The path needs both the act and the cash restoration, and neither is signalled today.
| KPI | Latest value | Status | What it tells us |
|---|---|---|---|
| Currency-neutral operating profit | −7.2% Q1 FY2026 | Cardinal | The swing variable for the quality leg. Negative ex-FX despite +6.1% revenue. Staying negative through FY2026 with an ex-FX margin below 9% falsifies the structural-margin reading and pulls fair value toward the bear. |
| FCF / EBIT conversion | 44% FY2025 | Watch | The structural counter of the thesis, down from 98% in FY2019. Restoration toward 55–60% by FY2027 validates the capex as a cycle ; persistence below 50% at FY12/26 is the stated stop. |
| Governance act | None FY2023–25 | Trigger | The only re-rating lever. A buyback above 3% of capital, a parent-stake reduction, or a royalty cap under the incoming CEO or new plan moves the dossier from watchlist to long. |
| Europe segment margin | 15.8% FY2025 | Holding | The margin anchor — but on a 9.0% return on capital, the lowest of the four poles. A durable break would test the highest-margin pole and the goodwill that sits behind it. |
| Return on capital (reported) | 7.8% FY2025 | Watch | Down from 8.9%, barely above the WACC near 7%. The incremental return on the growth capex is the real question behind the conversion collapse. |
| P/B | 1.02x | Reference | The valuation floor. Above 1.3x without a catalyst signals upside exhausted ; below 0.85x is an overshoot under the floor and a long-reinforcement window. |
| EV/EBITDA (FY2025 / forward) | 6.5x / 5.1x | Reference | Decade-low against a 10-year range of 5.9–12.7x. Misleading on the consolidated line given ~900bps of segment dispersion — read as a floor reference, not a value gap. |
The case turns positive on a governance act. A material buyback at 1.0x book, a reduction in the parent stake, or a cap on the intra-group royalty — announced under the incoming CEO or at the new mid-term plan — would reframe the discount as resorbable and move the dossier from watchlist to long, opening the bull path toward ~¥5,340. The lever is observable on the published calendar ; it is not signalled today.
The case turns negative if the quality leg fails. Currency-neutral operating profit staying negative through FY2026, or FCF/EBIT remaining below 50% at FY12/26, or a rise in the intra-group royalty rate versus FY2025 in the FY2026 Yuho, would falsify the underwriting and shift the bias to neutral or a structural short. Each is a stated stop.
The allocation risk is the one to watch most carefully, because it is the only path to a permanent loss. The ¥300–600bn growth-investment envelope of the 2030 plan could fund a value-destructive acquisition that deploys the net cash below the cost of capital, or a European goodwill impairment against ¥808bn of intangibles. Either, or a minority squeeze or increased parental extraction, converts a reversible timing disappointment into a permanent impairment and forces a complete re-underwriting. Currently not signalled.
The information provided on this website is for informational and educational purposes only and should not be construed as financial, investment, legal, or tax advice. All content reflects the personal opinions, interpretations, and analyses of the author at the time of writing and is subject to change without notice. Nothing contained herein constitutes, or should be interpreted as, a recommendation, solicitation, or offer to buy or sell any securities, financial instruments, or other investment products. The author is not a licensed financial advisor, broker, or investment professional. Any references to specific assets, markets, or strategies are illustrative in nature and do not constitute personalized investment advice. Investing in financial markets involves risk, including the potential loss of capital. Past performance is not indicative of future results. Readers are solely responsible for their own investment decisions and should conduct their own independent research and due diligence before making any financial commitments. You are strongly encouraged to consult with a qualified financial advisor, legal professional, or other relevant specialist before making any investment or financial decisions. By accessing and using this blog, you agree that the author shall not be held liable for any direct or indirect losses, damages, or consequences arising from the use of, or reliance on, the information presented herein. All content is provided "as is" without any warranties of completeness, accuracy, or reliability.